Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan V Mourich

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cellsCastle J Funatake, Nikki B Marshall, Linda B Steppan, et al.
Archives of Virology|March 29, 2008
Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomersChristopher Lupfer, David A Stein, Dan V Mourich, et al.
The Journal of Investigative Dermatology|February 20, 2009
Antisense targeting of cFLIP sensitizes activated T cells to undergo apoptosis and desensitizes responses to contact dermatitisDan V Mourich, Jessica L Jendrzejewski, Nikki B Marshall, et al.
Nucleic Acid Therapeutics|March 25, 2014
Induced IL-10 splice altering approach to antiviral drug discoveryRekha G Panchal, Dan V Mourich, Steven Bradfute, et al.
Immunotherapy|February 23, 2010
Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodesNancy I Kerkvliet, Linda B Steppan, William Vorachek, et al.
Viruses|December 4, 2012
Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infectionsPatrick L Iversen, Travis K Warren, Jay B Wells, et al.
Frontiers in Chemistry|March 10, 2022
Creating a Selective Nanobody Against 3-Nitrotyrosine Containing ProteinsElise M Van Fossen, Sonia Grutzius, Carl E Ruby, et al.
Nucleic Acid Therapeutics|February 6, 2014
Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD miceDan V Mourich, Shannon K Oda, Frederick J Schnell, et al.
Veterinary Sciences|July 25, 2025
Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in YeastKartikeya Vijayasimha, Andrew J Annalora, Dan V Mourich, et al.
Nature Medicine|August 24, 2010
Advanced antisense therapies for postexposure protection against lethal filovirus infectionsTravis K Warren, Kelly L Warfield, Jay Wells, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cellsCastle J Funatake, Nikki B Marshall, Linda B Steppan, et al.
Archives of Virology|March 29, 2008
Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomersChristopher Lupfer, David A Stein, Dan V Mourich, et al.
The Journal of Investigative Dermatology|February 20, 2009
Antisense targeting of cFLIP sensitizes activated T cells to undergo apoptosis and desensitizes responses to contact dermatitisDan V Mourich, Jessica L Jendrzejewski, Nikki B Marshall, et al.
Nucleic Acid Therapeutics|March 25, 2014
Induced IL-10 splice altering approach to antiviral drug discoveryRekha G Panchal, Dan V Mourich, Steven Bradfute, et al.
Immunotherapy|February 23, 2010
Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodesNancy I Kerkvliet, Linda B Steppan, William Vorachek, et al.
Viruses|December 4, 2012
Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infectionsPatrick L Iversen, Travis K Warren, Jay B Wells, et al.
Frontiers in Chemistry|March 10, 2022
Creating a Selective Nanobody Against 3-Nitrotyrosine Containing ProteinsElise M Van Fossen, Sonia Grutzius, Carl E Ruby, et al.
Nucleic Acid Therapeutics|February 6, 2014
Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD miceDan V Mourich, Shannon K Oda, Frederick J Schnell, et al.
Veterinary Sciences|July 25, 2025
Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in YeastKartikeya Vijayasimha, Andrew J Annalora, Dan V Mourich, et al.
Nature Medicine|August 24, 2010
Advanced antisense therapies for postexposure protection against lethal filovirus infectionsTravis K Warren, Kelly L Warfield, Jay Wells, et al.
Pageof 3